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Coronavirus disease 2019 (COVID-19) is a transmittable
infection caused by a new coronavirus. In the majority of
people, the disease causes mild to moderate respiratory symp-
toms, but COVID-19 can also cause severe symptoms and
even death, especially in older people and those with under-
lying health conditions (1). The virus has been transmitting in
the community and within families, including in the United
Kingdom, and was categorized as a pandemic on March 11,
2020 (2). Understandably, countries around the world have
escalated their responses to this global health emergency. In
the United Kingdom, the government’s aim has been to
reduce the rate of virus transmission so that it takes place over
months rather than weeks (3). This is to prevent the health
services from becoming overwhelmed with multiple cases
needing treatment all at the same time (4). The government’s
meaning of “health services” in this context, certainly at the
start of the crisis, is the care given in hospitals by nurses and
intensive care specialists. And in the community, mitigating
the impact of COVID-19 has to date focused largely on gen-
eral practitioners (GPs). This is unsurprising to those in the
pharmacy profession who have long considered policy makers
to overlook them (5). Yet, community pharmacists, a vital part
of the health workforce and trusted by many people (6), are
also facing huge additional pressures because of COVID-19
and struggle to highlight their plight.
An increasing number of people have been visiting com-
munity pharmacies during the COVID-19 pandemic. People
are worried. Many are unable to see or contact their GP for
reassurance because GP surgeries have been operating a
closed-door policy. This means that the only health care
professional available to many people is their community
pharmacist. Some people are turning up for consultations
with the pharmacist for more serious conditions which are
usually dealt with by GPs.
Another increasingly problematic behavior is the stock-
piling of medicines. Patients with chronic conditions who
rely on their prescriptions are reasonably worried, but some
are inundating pharmacies with their requests. Stocking up
on essential prescribed medicines coincides with an existing
shortage problem with some medicines in the United King-
dom. People are also trying to obtain medicines that they
have not needed for many years, such as inhalers for respira-
tory conditions, adding to supply problems and creating a
huge increase in the volume of prescriptions to dispense (7).
Some also want to stock up on over-the-counter remedies
such as paracetamol (8) In the United Kingdom, there is also
a national urge to mass-purchase hand sanitizers, nappies,
and antimicrobial wipes. These behaviors have created the
underpinnings of a perfect storm: countless fearful, stressed,
and easily angered people coming to pharmacies, which
remain open despite the obvious risks to staff’s own health.
In recognition of some of the additional demand on pharma-
cies, National Health Service (NHS) England has given per-
mission to community pharmacies to close their doors for up
to 2.5 hours per day, but as long as they remain open to the
public during core hours. Pharmacists, the unsung heroes on
our high streets, continue to serve their communities, but for
how long?
One of the huge problems facing community pharmacies
is the physical setup of practices. Despite the queues in some
pharmacies, efforts at imposing social distancing are some-
times difficult to manage. Patients can speak directly to the
counter assistants or ask to see the pharmacist who is often a
short distance away in the dispensing area. This close prox-
imity to patients places the community pharmacy workforce
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in direct contact with anyone who may be infected with the
coronavirus, thus posing a real risk of transmission. This was
brought to the fore with the failure to assign personal pro-
tective equipment (PPE), such as masks, gloves, and eye
protection to pharmacists (9). This places pharmacy teams
under even more pressure as they feel they are risking their
own health in already difficult circumstances. The NHS has
suggested the use of face masks for teams that cannot ensure
social distancing but as of mid-April had failed to provide
these systematically. Many pharmacies have begun purchas-
ing Perspex screens to shield their teams and providing PPE
to their staff if they can manage to source these.
There is another staff-related quandary. The government
guidelines in the United Kingdom are for individuals to self-
isolate for 14 days in the event of a relevant illness within the
home. At the time of writing this in April 2020, up to an
estimated 15% of staff in community pharmacies were
thought to be unable to attend work due to the coronavirus
(10). This is particularly problematic as community pharma-
cies are often composed of a small team of specifically
trained people (counter assistants, technicians, and pharma-
cist) and do not have the resilience or depth of trained staff to
continue operating in the event of large absences. There is
some guidance now to help pharmacies manage for short
periods without a pharmacist—for example, to hand out
already-prepared medicines or operate with a pharmacist at
the end of a video-call—but only when all other options are
exhausted. It is still possible for a pharmacy to have to close
altogether if too many of its staff are absent at the same time.
There are also reports of pharmacies closing to be deep-
cleaned because of potential contamination. This has
become a very difficult time for a sector that was already
under a lot of pressure from closures and funding cuts. There
is some relief after a recent promise of government funding
to try and mitigate some of the impact of the coronavirus on
community pharmacy, for example, to cover related closures
and some of the cost of delivering medicines to people hav-
ing to self-isolate. Since community pharmacies have long
been running prescription pick-up (from doctors/electroni-
cally) and drop-off services for the elderly, this should mean
that patients can continue to receive their medication.
But at the same time, there is a shortage of trained deliv-
ery drivers, many of whom are older people and may need to
self-isolate or might become ill themselves. For delivering
medicines, drivers have to be trained so pharmacies cannot
easily employ emergency cover. Pharmacies are receiving
increasing requests for deliveries, so sometimes they have to
ask patients or their representatives to collect the medication
instead. Delivery drivers too are rightfully worried. They
find themselves phoning ahead of a delivery, ringing the
doorbell, walking away, and observing the medicines being
picked up from the doorstep. No paperwork is signed by
patients to acknowledge receipt in case the virus is trans-
mitted in the exchange.
Some pharmacists wonder how long this can continue,
but they will keep going as they know that they are playing
a vital part in keeping people well in the community and
reducing hospital admissions. There has been a focus in the
UK press on people who have shouted abuse or complained
about community pharmacy staff due to a combustible mix
of fear and anger, maybe at the long waiting times or the
pharmacy’s inability to deliver. However, there are also
many heart-warming stories of members of the public com-
ing together to help their friends and neighbors while also
helping pharmacy teams by collecting medication. This is
reducing the pressure on deliveries. In some cases, local
people are even volunteering to manage social distancing
in the pharmacy queue. The authors thank all volunteers and
the patients who have expressed their gratitude to pharmacy
teams, which helps them to keep going.
As well as receiving help from volunteers, a number of
recent policy changes will prove useful too. For example,
pharmacy teams and their household contacts will be eligible
for coronavirus tests to allow those without the infection to
return to work. In addition, pharmacists will be able to order
PPE from an NHS website. Pharmacists ideally want input
into future policy changes before they are finalized, so that
these can reflect capacity and preparedness on the ground
and be publicized accurately. Medicines deliveries are a case
in point: although the UK government is funding deliveries
for “vulnerable people,” this is for a narrower group than
most patients understand it to be, raising unrealistic expec-
tations and leaving pharmacies to pay for a large number of
the deliveries to placate patient concerns. No doubt formal
extra recruitment into community pharmacies, whether via
the recent government volunteer scheme (if volunteers are
appropriately vetted and trained) or through additional
monies, will also help meet some of the current challenges.
Additional funding for community pharmacy is particularly
needed at this time—the normal method of reimbursement
for dispensing medicines is months in arrears, which is leav-
ing many pharmacies with cash flow problems, unable to
purchase new medicines, because of unprecedented
increases in prescription numbers. The resulting drug
shortages in some localities might also be better managed
by addressing quotas imposed by manufacturers on commu-
nity pharmacies. Finally, some pharmacies have called on
GPs who are either closed or only offering limited services,
to be clearer to patients on how they can order their prescrip-
tions, to limit the unnecessary footfall in pharmacies.
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